It was also observed that altered GPx expression was present in CML, where the promoter of GPX3 was hypermethylated, which in turn correlated with the lowered expression of GPX3 [53]. This evidence concerns the gene GPX3 and chronic myelogenous leukemia, BCR-ABL1 positive.